Lídia Robert
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Melanoma and MAPK Pathways 11
- Protein Degradation and Inhibitors 2
- Oncology 12
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Antoni Ribas (22 shared papers)Thomas G. Graeber (12 shared papers)Jennifer Tsoi (10 shared papers)Blanca Homet Moreno (7 shared papers)Siwen Hu‐Lieskovan (4 shared papers)Richard C. Koya (6 shared papers)Stephen Mok (5 shared papers)Deborah J. Wong (4 shared papers)
- Journals
- Cancer Research (5 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer (2 papers)Clinical Cancer Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Lídia Robert
26 papers receiving 3.8k citations
Lídia Robert's Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 1.8k
- Immunology 1.2k
- Cancer Research 492
- Molecular Biology 1.9k
- Cell Biology 323
Countries citing papers authored by Lídia Robert
This map shows the geographic impact of Lídia Robert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lídia Robert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lídia Robert more than expected).
Fields of papers citing papers by Lídia Robert
This network shows the impact of papers produced by Lídia Robert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lídia Robert. The network helps show where Lídia Robert may publish in the future.
Co-authors
The 25 scholars most cited alongside Lídia Robert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress Hit paper breakdown → | 2018 | 605 |
| 2 | Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma Hit paper breakdown → | 2015 | 452 |
| 3 | Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma Hit paper breakdown → | 2014 | 438 |
| 4 | 2000 | 321 | |
| 5 | 2014 | 293 | |
| 6 | 2014 | 291 | |
| 7 | 2013 | 256 | |
| 8 | 2015 | 182 | |
| 9 | 2017 | 159 | |
| 10 | 2014 | 156 | |
| 11 | 2018 | 125 | |
| 12 | 2016 | 106 | |
| 13 | 2014 | 89 | |
| 14 | 2011 | 76 | |
| 15 | 2014 | 67 | |
| 16 | 2014 | 67 | |
| 17 | 2016 | 51 | |
| 18 | 2015 | 38 | |
| 19 | 2019 | 34 | |
| 20 | 2017 | 34 |
About Lídia Robert
Lídia Robert is a scholar working on Molecular Biology, Oncology, Immunology, Pathology and Forensic Medicine and Computational Theory and Mathematics, having authored 26 papers that have together received 3.9k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (11 papers), CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Mechanisms and Therapy (4 papers), Computational Drug Discovery Methods (4 papers), Protein Degradation and Inhibitors (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (1.2k citations), Cancer Research (492 citations), Molecular Biology (1.9k citations) and Cell Biology (323 citations). Lídia Robert has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Antoni Ribas, Thomas G. Graeber, Jennifer Tsoi, Blanca Homet Moreno, Siwen Hu‐Lieskovan, Richard C. Koya, Stephen Mok, Deborah J. Wong, Mohammad Atefi and Begoña Comı́n-Anduix. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Molecular Cancer, Clinical Cancer Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.